News

Hospitals serving Medicaid patients prepare to take proposed payment caps on the chin

New federal limits on state-directed payments are set to cut Medicaid funding in most states. Hospitals are expected to bear the brunt since they account for the majority—84%, around $78B a year—of state-directed healthcare spends.

older patient with a doctor at their house

AFib patients with gout face greater stroke risk—but therapy can help

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.

Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.

High-intensity ultrasound technology for calcified valve leaflets makes debut in Europe

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT

CCTA scan at conference gives cardiologist a wake-up call

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care.

exercise aerobic training fitness resistance training older woman

Resistance training reduces heart attack risk in women

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

Boston researchers land $9M grant to advance molecular neuroimaging

Researchers in Boston are set to co-lead a long-term study on the aging brain and factors that make individuals more vulnerable to neural injury and cognitive decline.

OhioHealth agrees to void contracts that allegedly punished payers for including competitors in-network

The U.S. Department of Justice said the settlement will save citizens of the state money and open up the market to competition.

Nationwide nursing-home picture comes into focus with new analysis

Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.

Boston Scientific said it initiated the AGENT DCB STANCE trial to assess the safety and effectiveness of the Agent Drug-Coated Balloon (DCB) compared to the standard of care using either percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and/or balloon angioplasty. The trial will enroll more than 1,600 patients and is expected to a primary completion date in 2028.

Boston Scientific launches study comparing drug-coated balloons to standard care

"This important study will evaluate the potential benefits of the AGENT DCB for patients with certain anatomical features in de novo coronary lesions, where the avoidance of stents is preferable to help circumvent potential complications,” said Janar Sathananthan, MD, chief medical officer, interventional cardiology therapies, Boston Scientific.

New MRI findings may explain why some amputees struggle with phantom pain

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage.

Eko Health announced former U.S. Surgeon General Jerome Adams, MD, MPH, FASA, a board-certified anesthesiologist and executive director of the Center for Community Health Enhancement and Learning at Purdue University, joined the company as a distinguished medical advisor.

Former US surgeon general joins Eko as medical advisor

"Eko is transforming how we detect cardiovascular disease—making cutting-edge, AI-powered tools accessible to frontline providers," said former U.S. Surgeon General Jerome Adams, MD.

Australia-based Artrya Limited said its Salix Coronary Plaque module AI-powered cloud platform offers near-real time, point-of-care CCTA assessment and management of coronary artery disease.

FDA clears CCTA AI coronary plaque assessment from Artrya

Australia-based Artrya Limited says its AI-enabled Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment and management of coronary artery disease.

Around the web

Health Exec